Advertisement

Taking Action

Advocacy

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • Policy Matters

    Research Advocacy During COVID-19

    Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.

    by Brandon Leonard, MA, and Marc Johnson, MPP

  • Q&A

    Up for Debate

    Hematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.

    by Marci A. Landsmann

  • Survivor Profile

    A Return to Carnival

    With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.

    by Lindsey Konkel

  • A Drive for Diversity

    African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

    by Jon Kelvey

  • Patient Advocates Tune in for Precision Medicine Primer

    Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

    by Kevin McLaughlin

  • Immunotherapy Options for Breast Cancer

    Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

    by Anna Goshua

  • Living Beyond a Diagnosis

    Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.

    by Judy Pearson

  • Policy Matters

    Cancer Scientists Support COVID-19 Response

    Researchers study ways to improve telehealth capabilities, clinical trials and health disparities.

    by Trevan Locke, PhD

  • Q&A

    Ethics in Practice

    Rebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.

    by Marci A. Landsmann